Arrive AI gets Nasdaq minimum bid price notice
Arrive AI Inc. reported that Nasdaq sent a deficiency letter on June 2, 2026 because its common stock failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days under Nasdaq Listing Rule 5450(a)(1).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arrive AI Inc. reported that Nasdaq sent a deficiency letter on June 2, 2026 because its common stock failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days under Nasdaq Listing Rule 5450(a)(1).
The company has 180 calendar days, until November 30, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for ten consecutive business days. If it still falls short, Arrive AI may qualify for a second 180‑day period if other Nasdaq Global Market initial listing standards are met, or face potential delisting with the right to appeal.
Positive
- None.
Negative
- Nasdaq minimum bid-price deficiency: Arrive AI’s stock traded below $1.00 for 30 consecutive business days, triggering a Nasdaq notice and starting a 180‑day cure period with potential delisting if compliance is not restored.
Insights
Nasdaq bid-price warning introduces real listing-risk over the next compliance periods.
Arrive AI received a Nasdaq deficiency notice after its stock traded below $1.00 for 30 straight business days, triggering the exchange’s Minimum Bid Price Requirement under Rule 5450(a)(1). The stock remains on the Nasdaq Global Market during the initial cure period.
The company has until November 30, 2026 to post a closing bid at or above $1.00 for at least ten consecutive business days. Nasdaq rules also allow a possible second 180‑day window if all other initial listing standards, including market value of publicly held shares, are satisfied.
Management states it will monitor the share price and evaluate options to regain compliance, while acknowledging there is no assurance of success. If the requirements are not met, Nasdaq can move toward delisting, though Arrive AI could appeal that decision to a hearings panel.
8-K Event Classification
Key Figures
Key Terms
Minimum Bid Price Requirement regulatory
Nasdaq Global Market regulatory
deficiency letter regulatory
Listing Qualifications Department regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq issue did Arrive AI (ARAI) disclose in this 8-K?
Why is Arrive AI (ARAI) out of compliance with Nasdaq listing rules?
How long does Arrive AI have to regain Nasdaq minimum bid price compliance?
Can Arrive AI (ARAI) receive additional time beyond November 30, 2026?
What happens if Arrive AI does not regain Nasdaq compliance?
What actions does Arrive AI plan in response to the Nasdaq notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.